Citations for
1MPO, MPOD
Loss-of-Function Myeloperoxidase Mutations Are Associated with Increased Neutrophil Counts and Pustular Skin Disease.
Vergnano M, Mockenhaupt M, Benzian-Olsson N, Paulmann M, Grys K, Mahil SK, Chaloner C, Barbosa IA, August S, Burden AD, Choon SE, Cooper H, Navarini AA, Reynolds NJ, Wahie S, Warren RB, Wright A; APRICOT and PLUM study team, Huffmeier U, Baum P, Visvanathan S, Barker JN, Smith CH, Capon F.
Am J Hum Genet. Sep 3;107(3):539-543. doi: 10.1016/j.ajhg.2020.06.020. Epub 2020 Aug 5. 2020
2MPO, MPOD
Impact of two novel mutations on the structure and function of human myeloperoxidase.
Goedken M, McCormick S, Leidal KG, Suzuki K, Kameoka Y, Astern JM, Huang M, Cherkasov A, Nauseef WM.
J Biol Chem 282(38):27994-8003. Epub 2007 Jul 24. 2007
3MPO, MPOD
A novel form of hereditary myeloperoxidase deficiency linked to endoplasmic reticulum/proteasome degradation.
DeLeo FR, et al.
J Clin Invest 101 : 2900-2909. 1998
4MPO, MPOD
Biochemical and molecular characterization of hereditary myeloperoxidase deficiency.
Romano M, Dri P, Dadalt L, Patriarca P, Baralle FE.
Blood 90(10):4126-34. 1997
5MPO, MPOD
Hereditary myeloperoxidase deficiency due to a missense mutation of arginine 569 to tryptophan.
Nauseef WM, et al.
J Biol Chem 269 : 1212-1216. 1994